Skip to content
healthcare.dev

memantine hydrochloride

NDC 68180-248, memantine hydrochloride, capsule, extended release, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-248
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206028
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-248 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEMANTINE HYDROCHLORIDE21 mg/1

Pharmacologic classes

N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
68180-248-066818002480630 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-248-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24290655-47f3-4042-a977-a832c5161d2c
  • NADAC price for package 68180024806

    GET /v1/drugs/nadac/68180024806

Use it

Look up 68180-248 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-248 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-248. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.